JPS55122720A - Adjuvant for neutron capture therapy for skin cancer - Google Patents

Adjuvant for neutron capture therapy for skin cancer

Info

Publication number
JPS55122720A
JPS55122720A JP3020979A JP3020979A JPS55122720A JP S55122720 A JPS55122720 A JP S55122720A JP 3020979 A JP3020979 A JP 3020979A JP 3020979 A JP3020979 A JP 3020979A JP S55122720 A JPS55122720 A JP S55122720A
Authority
JP
Japan
Prior art keywords
adjuvant
skin cancer
boronophenylalanine
neutron capture
capture therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3020979A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6318567B2 (enrdf_load_stackoverflow
Inventor
Yutaka Mishima
Hidetake Kakihana
Masamitsu Okamoto
Kazuo Yoshino
Kazuhiko Konno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Petrochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Petrochemical Co Ltd filed Critical Mitsubishi Petrochemical Co Ltd
Priority to JP3020979A priority Critical patent/JPS55122720A/ja
Publication of JPS55122720A publication Critical patent/JPS55122720A/ja
Publication of JPS6318567B2 publication Critical patent/JPS6318567B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
JP3020979A 1979-03-15 1979-03-15 Adjuvant for neutron capture therapy for skin cancer Granted JPS55122720A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3020979A JPS55122720A (en) 1979-03-15 1979-03-15 Adjuvant for neutron capture therapy for skin cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3020979A JPS55122720A (en) 1979-03-15 1979-03-15 Adjuvant for neutron capture therapy for skin cancer

Publications (2)

Publication Number Publication Date
JPS55122720A true JPS55122720A (en) 1980-09-20
JPS6318567B2 JPS6318567B2 (enrdf_load_stackoverflow) 1988-04-19

Family

ID=12297332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3020979A Granted JPS55122720A (en) 1979-03-15 1979-03-15 Adjuvant for neutron capture therapy for skin cancer

Country Status (1)

Country Link
JP (1) JPS55122720A (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4516535A (en) * 1982-06-22 1985-05-14 Nuclear Medicine, Inc. Methods for neutron-capture tumor therapy
US5492900A (en) * 1993-09-10 1996-02-20 Neutron Technology Corporation Method for enhancing the solubility of the boron delivery drug, boronophenylalanine (BPA)
US5935944A (en) * 1993-09-10 1999-08-10 Neutron Technology Corporation Formulation for I.V. administration of the boron delivery drug, boronophenylalanine (BPA)
JP2006096870A (ja) * 2004-09-29 2006-04-13 Stella Chemifa Corp ホウ素含有化合物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0229946U (enrdf_load_stackoverflow) * 1988-08-10 1990-02-26

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4516535A (en) * 1982-06-22 1985-05-14 Nuclear Medicine, Inc. Methods for neutron-capture tumor therapy
US4675150A (en) * 1982-06-22 1987-06-23 Theragenics Corporation Apparatus for neutron-capture tumor therapy
US5492900A (en) * 1993-09-10 1996-02-20 Neutron Technology Corporation Method for enhancing the solubility of the boron delivery drug, boronophenylalanine (BPA)
US5935944A (en) * 1993-09-10 1999-08-10 Neutron Technology Corporation Formulation for I.V. administration of the boron delivery drug, boronophenylalanine (BPA)
JP2006096870A (ja) * 2004-09-29 2006-04-13 Stella Chemifa Corp ホウ素含有化合物

Also Published As

Publication number Publication date
JPS6318567B2 (enrdf_load_stackoverflow) 1988-04-19

Similar Documents

Publication Publication Date Title
JPS5735516A (en) Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
JPS55122720A (en) Adjuvant for neutron capture therapy for skin cancer
JPS5340181A (en) Core part structure of reactor
Malaise et al. Measurements in vitro with three cell lines derived from melanomas
JPS5441856A (en) 1 hydroxyy244oxoovitamin d3 and its preparation
JPS5263588A (en) Neutraon source for nuclear reactor
JPS522777A (en) Radiation detector
JPS5277999A (en) Shielding block for neutron
JPS5234023A (en) High shrinkage copolyester fibers and their preparation
JPS5433991A (en) Fast breeder
JPS5347790A (en) Shooting method for x-ray tomogram device
JPS527041A (en) Solar heat collector
Nakamura Hyperthermia
GEORGE Space Nuclear Safety Program(Progress Report, Jun. 1984)
JPS52112094A (en) Nuclear reactor
JPS5235340A (en) Solar energy absorbing body
金继荣 et al. The Double Effects and Mechanism of Slow Neutron Irradiation on HTSC
JPS53141887A (en) Nuclear fuel assembly
Schlag Proliferation kinetics and survival of mammal cells after treatment with radiation of various ionization densities and with hyperthermia
Myers et al. Biological effects of low doses of ionizing radiation: three review papers
Shehata et al. Ovarian carcinoma: Role of radiation therapy versus chemotherapy
JPS51124789A (en) A fast breeder
Ichihashi et al. Thermal Neutron Capture Therapy Using 10B1-Bpa: Inducement of Marked Lethal Effect on Melanoma Cells Irrespective of X-Ray Sensitivity
Lytkin et al. Radiation treatment of postoperative recurrence of lung cancer
Harling et al. A clinical trial of neutron capture therapy for brain cancer